European Direct-to-Consumer Genetic Testing Market to Reach USD 3.78 Billion by 2035, Says Meticulous Research®
Market Growth Driven by Increasing Consumer Awareness About Personalized Medicine, Growing Interest in Ancestry Research, Rising Prevalence of Chronic Diseases, and Technological Advancements in Genomic Sequencing
REDDING, Calif., June 17, 2025 /PRNewswire/ -- The European direct-to-consumer genetic testing market is expected to reach USD 3.78 billion by 2035, growing from an estimated USD 464 million in 2025, at a CAGR of 23.3% during the forecast period of 2025-2035, according to a new market research report titled "Europe Direct-to-Consumer (DTC) Genetic Testing Market by Test Type (Health, Ancestry, Nutrigenomics, Pharmacogenetics), Technology, Sample Type, Distribution Channel & Region – Forecast to 2035", published by Meticulous Research®.
The European DTC genetic testing market is primarily driven by increasing consumer awareness about personalized medicine, growing interest in ancestry and genealogy research, rising prevalence of chronic diseases, and technological advancements in genomic sequencing. The shift towards comprehensive health and wellness testing panels and focus on user-friendly sample collection methods are reshaping the industry, while enhanced data privacy compliance and regulatory frameworks are gaining significant traction.
The integration with digital health platforms and telemedicine services and the development of AI-powered genetic interpretation tools are further driving market growth, especially in developed European markets with advanced healthcare infrastructure. Additionally, the growing focus on preventive healthcare and wellness optimization, along with increasing adoption of multi-omics approaches combining genomics with other biological data, are creating new revenue streams for solution providers.
Key Market Drivers and Trends
The European DTC genetic testing market is experiencing significant transformation through technological advancements in genomic sequencing, AI-powered genetic interpretation tools, and integration with digital health platforms. Leading genetic testing companies are investing heavily in comprehensive testing panels, user-friendly sample collection methods, and enhanced data privacy compliance to improve user experience and expand market reach. These advances are enabling consumers to access personalized health insights while maintaining regulatory compliance across diverse European markets.
Recent developments in next-generation sequencing technologies and pharmacogenetic testing capabilities have significantly improved analytical accuracy and clinical utility. The integration of telemedicine services and genetic counseling platforms has transformed DTC genetic testing from simple ancestry analysis into comprehensive health management tools.
Read more about the European Direct-to-Consumer Genetic Testing Market- https://www.meticulousresearch.com/product/europe-direct-to-consumer-genetic-testing-market-6184
Market Segmentation Insights
Health & Disease Predisposition Testing Segment Projected to Hold the Largest Market Share
The Health & Disease Predisposition Testing segment is expected to hold the largest share of the overall European DTC genetic testing market in 2025, due to increasing consumer interest in understanding genetic risks for common diseases and growing awareness of preventive healthcare. This segment benefits from rising chronic disease prevalence and consumer demand for proactive health management strategies.
However, the Nutrigenomics & Metabolism Testing segment is expected to grow at the fastest CAGR during the forecast period, driven by increasing focus on personalized nutrition, wellness optimization trends, and growing understanding of gene-diet interactions.
Next-Generation Sequencing (NGS) Experiencing Highest Growth by Technology
The DNA Microarrays segment is expected to dominate the overall European DTC genetic testing market in 2025, primarily due to its cost-effectiveness and suitability for common genetic variant analysis. However, the Next-generation Sequencing (NGS) segment is expected to grow at the fastest CAGR through the forecast period, driven by decreasing sequencing costs, enhanced analytical capabilities, and growing demand for comprehensive genomic profiling.
Online Platforms Dominate Distribution Channel
The Online Platforms segment is expected to hold the largest share of the European DTC genetic testing market in 2025, due to the direct-to-consumer nature of these tests and increasing e-commerce adoption. However, the Health Clinics & Laboratories segment is expected to experience the fastest growth rate during the forecast period, driven by increasing integration of genetic testing into routine healthcare and growing physician awareness of genetic testing benefits.
Request a customized research analysis tailored to your specific requirements: https://www.meticulousresearch.com/request-customization/cp_id=6184
Regional Market Analysis
Netherlands and Nordic Countries to Exhibit the Highest Growth
The Netherlands and Nordic countries (Sweden, Denmark, Norway) are witnessing rapid growth rates during the forecast period, primarily driven by progressive healthcare policies, high digital literacy, growing focus on preventive healthcare, and strong government support for genomic medicine initiatives. These regions benefit from advanced healthcare infrastructure and favorable regulatory environments for genetic testing innovation.
Germany is expected to hold the largest share of the European DTC genetic testing market in 2025, driven by advanced healthcare infrastructure, high consumer awareness about genetic testing, and significant investments in personalized medicine research, while the U.K. follows as the second-largest market, bolstered by established genetic research institutions and high adoption of digital health technologies.
For more comprehensive insights, download the FREE report sample: https://www.meticulousresearch.com/download-sample-report/cp_id=6184
Market Challenges and Opportunities
The European DTC genetic testing market faces challenges including stringent regulatory requirements under GDPR and medical device regulations, concerns about data privacy and genetic discrimination, limited clinical utility of some genetic tests, and varying regulatory frameworks across European countries. Additionally, reimbursement limitations for DTC genetic testing, ethical concerns regarding incidental findings, and the need for genetic counseling services present significant obstacles.
Despite these constraints, the market offers substantial growth opportunities through development of pharmacogenetic testing for personalized medication selection, expanding partnerships with healthcare providers, and integration into routine medical care. The growing focus on preventive healthcare and wellness optimization creates new avenues for comprehensive genetic testing solutions.
Competitive Landscape
The European direct-to-consumer genetic testing market features a diverse competitive landscape with established genetic testing companies, biotechnology specialists, digital health solution providers, and innovative genomics startups pursuing varied approaches to consumer genetic testing implementation.
The key players operating in the European DTC genetic testing market include 23andMe, Inc., Ancestry.com LLC, MyHeritage Ltd., Living DNA Ltd., Dante Labs S.r.l., tellmeGen S.L., Prenetics Global Limited, Chronomics Limited, GenePlanet d.o.o., ADNTRO Genetics S.L., LetsGetChecked Ltd., Veritas Genetics, Inc., and several other regional and emerging players focusing on specialized genetic testing applications.
Leading providers are focusing on comprehensive testing panels that combine multiple genetic insights with personalized health recommendations while addressing region-specific regulatory requirements and privacy concerns. These companies are forming strategic partnerships with healthcare providers, digital health platforms, and research institutions to create integrated genetic testing ecosystems.
Recent Industry Developments
Companies across the European DTC genetic testing sector continue to invest heavily in technological advancement, regulatory compliance, and expansion into new therapeutic areas. Major players are focusing on developing AI-powered interpretation tools, enhancing data privacy protections, and creating specialized testing panels for specific population groups and health conditions.
Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More)- https://www.meticulousresearch.com/view-pricing/1501
Related Industry Reports:
Europe DTC Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, Thyroid, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Forecast to 2032
https://www.meticulousresearch.com/product/europe-dtc-laboratory-testing-market-5641
Europe Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis) Platform (LFA, Molecular) Sample, and End User - Forecast to 2032
https://www.meticulousresearch.com/product/europe-point-of-care-diagnostics-market-5650
Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Forecast to 2032
https://www.meticulousresearch.com/product/europe-molecular-diagnostics-market-5710
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence, strategic insights, and consulting services to serve clients across 11 major industries globally. The company serves various clients across academics and business leaders from startups to Fortune 500 companies.
Meticulous Research® offers comprehensive market research reports, custom research, and consulting services. Our research studies help clients make informed business decisions and understand emerging business trends and opportunities. The company's expertise spans across various domains, enabling it to provide accurate insights and strategic recommendations to its clients. Meticulous Research® is committed to providing accurate and granular research reports to the global business community.
To find out more, visit www.meticulousresearch.com or follow us on LinkedIn
Contact:Meticulous Market Research Pvt. Ltd.1267 Willis St, Ste 200 Redding,California, 96001, U.S. USA: +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- sales@meticulousresearch.comVisit Our Website: https://www.meticulousresearch.com/Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-researchContent Source: https://www.meticulousresearch.com/product/europe-direct-to-consumer-genetic-testing-market-6184
Logo: https://mma.prnewswire.com/media/1757980/5251440/Meticulous_Research_Logo_1.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/european-direct-to-consumer-genetic-testing-market-to-reach-usd-3-78-billion-by-2035--says-meticulous-research-302483701.html
SOURCE Meticulous Market Research Pvt. Ltd.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
MODE Global Technology Suite Gains Momentum
DALLAS, June 17, 2025 /PRNewswire/ -- MODE Global, a leading third-party logistics (3PL) provider, has launched two integral parts of their technology suite: MODE VPO, a machine learning (ML) driven optimization tool, and MODE IQ, a digital freight enablement tool. The addition of these digital tools to MODE's extensive transportation solutions provides an additional layer of insight into supply chains with the intention to improve visibility and planning. MODE VPO provides a clear line of sight to a customer's active and historic lanes and compares that to MODE's entire network, highlighting areas for cost improvements as well as backhaul and consolidation opportunities through machine learning and predictive analytics tied into the MODE Data Cloud. These insights allow a customer to better optimize their supply chain processes and improve overall visibility, including the ability to view lanes that could benefit from switching modes from both a cost and emissions perspective. MODE IQ is a digital freight management tool that uses predictive rating and machine learning capabilities to create a frictionless carrier experience through automated bid board quoting and load matching. The goal is to minimize the amount of time spent on non-value add activities, freeing up carriers to focus on more business-critical activities like customer service and carrier relationship management. "We're building a more intuitive and innovative supply chain," said Jason Roberts, MODE's SVP of digital enablement, "Making it easier than ever for customers, carriers and our employee and agent groups to capitalize on efficiencies and become more effective not only in their day-to-day interactions but also throughout the entire supply chain." "The operational efficiencies that can be leveraged through these tools is no small thing, especially as it helps multiple stakeholders throughout the supply chain," said Lance Malesh, president and CEO of MODE Global. "Our vision is to be the trusted partner in logistics, and that means not only executing on transportation solutions but also providing customers and carriers with better tools that continuously improve their overall processes and workflows." MODE Global continues to build out their technology suite in an effort to simplify stakeholder experiences while simultaneously providing more value to supply chains. To find out more about MODE Global's current technology suite, visit their website. About MODE Global MODE Global is a multi-billion, multi-brand, 3PL platform and one of the world's leading logistics companies. We are the eighth-largest truckload freight brokerage and the largest non-asset intermodal provider in the United States. Through our family of brands, which includes Avenger Logistics, MODE Transportation and SUNTECKtts, we offer more than 30 years of experience providing exceptional service with a focus on customer experience. MODE Global delivers efficient, reliable transportation services around the world to more than 10,000 customers across a diverse set of markets. Powered by a sophisticated suite of technology solutions, MODE makes supply chain management easy through relationships with more than 100,000 carriers and agents in 230 locations throughout North America. For more information on how to transform your shipping solutions, please visit CONTACTMODE Global Communicationsmodecommunications@ View original content to download multimedia: SOURCE MODE Global
Yahoo
36 minutes ago
- Yahoo
LEADING RETIREMENT SOLUTIONS RESCUES CANNABIS INDUSTRY WITH MOST COMPLIANT CANNABIS 401(K) BENEFITS ON THE MARKET
Leading Retirement Solutions' Cannabis 401(k) helps cannabis leadership avoid plan ejections through comprehensive compliance and risk mitigation support SEATTLE, June 17, 2025 /PRNewswire/ -- Today, 51 states in the U.S. have legalized medical cannabis, 28 U.S. jurisdictions have legalized recreational cannabis, and according to data from Statista, the U.S. market is expected to generate $45.35 billion in 2025. But, despite the continued prosperity of the industry, traditional banking—and vital benefits like 401(k) plans—are out of reach for most state-licensed cannabis companies and their employees. Because they are federally-regulated, most U.S. banks and depository institutions do not want to take the legal risks to work with cannabis, which is still illegal to manufacture, distribute, and dispense under federal law. In particular, banks fear that working in the cannabis industry will violate federal anti-money laundering laws, including The Bank Secrecy Act (BSA), which would put them at risk of legal penalties. But, working with cannabis companies doesn't need to be so fraught for financial service providers or cannabis operators. Since 2017, Leading Retirement Solutions has offered stable, safe, compliant and affordable cannabis 401(k) solutions that comprehensively mitigate the risks financial institutions face and protect cannabis companies from plan ejections and legal issues. In fact, they were the very first company to tackle this issue for the industry, with compliance at the forefront. "I certainly had a lot of anxiety about being responsible for rolling out our plan correctly from a legal perspective and communicating about it with employees," said Alissa Jubelirer, a lawyer who specializes in labor and employment law and cannabis at Benesch. In her previous role as General Counsel to Revolution Cannabis Co., she was responsible for rolling out the company's first 401(k) plan with LRS. "LRS did a great job of holding my hand through the process, project managing, and addressing expectations on our end so we could deliver the best possible benefit to our employees. It was just a great experience overall," she said. LRS delivers such services through access to diverse investments specifically approved for cannabis-related plans. Likewise, they implement various layers of oversight to ensure compliance, including rigorous Know-Your-Client (KYC) procedures, a set of standards in the investment industry that help advisors build trust with regulators, as well as thorough risk evaluations and extensive transaction monitoring to detect and report suspicious activity. LRS provides ample education and integrated payroll solutions to make managing contributions simple and to limit plan violations. By ensuring compliance, LRS builds trust with regulators and other key stakeholders at the intersection of cannabis and retirement savings and delivers cannabis companies the most trustworthy cannabis 401(k) services on the market. Consequently, they've maintained a diverse and long-standing roster of cannabis clients, from micro-cannabis businesses to the largest, multi-state operators in the country. As Jubelirer said, "The fact that LRS has been offering compliant 401(k)'s to cannabis companies for as long as they have and that they invested in cannabis when a lot of other plan providers didn't, has led me to recommend LRS time and time again." More About Leading Retirement Solutions: Leading Retirement Solutions is an industry leader in innovative retirement plan solutions for businesses. LRS focuses on improving retirement strategies by offering custom-fit solutions and nontraditional investment opportunities. Their services include plan design, plan administration, recordkeeping, consulting, and more. Leading Retirement Solutions prides itself on helping fellow women-owned businesses, not-for-profit organizations, cannabis, and small businesses, through tax sheltering and employee benefits. For more tips and information regarding retirement plans, contact marketing@ Connect with us on Facebook, LinkedIn, and X! View original content to download multimedia: SOURCE Leading Retirement Solutions Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
GATEGROUP CLOSES CHF 1.4B REFINANCING TO STRENGTHEN FINANCIAL POSITION AND SUPPORT LONG-TERM STRATEGY
Zurich, June 17, 2025 – gategroup Holding AG and its subsidiaries ('gategroup' or the 'Group') have successfully closed a comprehensive refinancing package consisting of a EUR 675 million term loan, a USD 500 million term loan and a CHF 300 million multicurrency revolving credit facility. The transaction supports the Group's ongoing transformation, enhances its financial flexibility and positions it for continued growth. The new financing marks gategroup's debut as a Term Loan B (TLB) issuer and was priced on May 28, 2025 at the tighter end of the original guidance. The company is pleased to have attracted strong demand from a broad syndicate of top-tier global institutional investors and banking partners. Proceeds from the refinancing will be used to repay existing indebtedness, including a EUR 250 million term loan A and a CHF 415 million revolving credit facility, as well as other loans and accrued interest. The transaction also provides additional liquidity for general corporate purposes. 'This successful refinancing represents a key milestone for gategroup. It reflects strong market confidence in our business and creates a solid capital structure to support our long-term strategic ambitions,' said Urs Schwendinger, Chief Financial Officer of gategroup. 'With an extended maturity profile and improved financial flexibility, we are well positioned to drive operational excellence and growth across our global platform.' The closing of the refinancing will lead to ratings upgrades by both Moody's and S&P Global. The new corporate ratings are B2 and B+ respectively. For media and investor inquiries, please contact: IR@ About gategroupgategroup is the global leader in airline catering, retail-on-board, and hospitality products and services. Headquartered in Zurich, Switzerland, gategroup operates over 200 units in more than 60 countries, delivering culinary and retail excellence to passengers across all continents. Learn more at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
